The treatment success rate for multidrug-resistant tuberculosis (MDR-TB) in India was 44% in 2023. Forecasts from 2024 to 2028 show a slight decline, maintaining at 43% for 2024 and 2025, then decreasing to 42% from 2026 onward. Year-on-year variation over the last two years is -1%, with no change projected from 2025 to 2028, resulting in a negative CAGR over five years.
Future trends to watch for include technological advancements in diagnostics and treatment, policy changes, and resource allocations, which could affect treatment success rates positively or negatively.
